Revance Therapeutics Inc. (RVNC)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

3.08

-0.16%

After-hours Dec 13, 2024, 07:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	234.04M	132.56M	77.80M	15.32M	413.00K	3.73M	262.00K	300.00K	300.00K	383.00K	617.00K	717.00K	557.00K
Cost of Revenue	152.16M	51.67M	23.41M	4.77M	102.86M	92.50M	-	-	2.00M	-	-	-	5.00K
Gross Profit	81.88M	80.90M	54.39M	10.56M	-102.45M	-88.77M	262.00K	300.00K	-1.70M	383.00K	617.00K	717.00K	552.00K
Operating Income	-316.78M	-272.17M	-274.68M	-273.16M	-164.46M	-142.63M	-120.42M	-88.22M	-72.32M	-52.05M	-38.23M	-43.19M	-27.74M
Interest Income	13.29M	4.89M	337.00K	4.32M	5.53M	4.02M	1.41M	1.17M	231.00K	44.00K	2.00K	7.00K	15.00K
Pretax Income	-323.69M	-355.72M	-281.31M	-284.71M	-159.43M	-139.57M	-120.59M	-89.27M	-73.48M	-62.92M	-52.45M	-58.26M	-44.86M
Net Income	-323.99M	-356.42M	-286.82M	-282.09M	-156.22M	-142.57M	-120.59M	-89.27M	-73.48M	-62.92M	-52.45M	-58.26M	-44.86M
Selling & General & Admin	292.24M	223.93M	198.82M	151.85M	62.01M	53.86M	37.40M	29.07M	25.09M	19.04M	11.01M	11.20M	5.55M
Research & Development	79.41M	101.29M	116.25M	125.80M	102.86M	92.50M	80.36M	50.38M	47.53M	33.39M	27.83M	32.71M	22.73M
Other Expenses	27.01M	27.85M	13.99M	6.08M	-303.00K	-773.00K	-525.00K	-535.00K	-327.00K	-234.00K	-404.00K	-106.00K	170.00K
Operating Expenses	398.65M	353.07M	329.06M	283.72M	164.87M	146.36M	117.76M	79.46M	72.62M	52.43M	38.84M	43.90M	28.29M
Interest Expense	19.36M	16.47M	6.27M	15.15M	-	44.00K	457.00K	1.08M	1.19M	10.67M	15.16M	28.96M	17.79M
Selling & Marketing Expenses	253.42M	183.10M	166.42M	2.10M	-	-	-	-	-	-	-	-	-
Cost & Expenses	550.82M	404.73M	352.47M	288.49M	164.87M	146.36M	117.76M	79.46M	72.62M	52.43M	38.84M	43.90M	28.30M
Income Tax	300.00K	700.00K	5.51M	-2.62M	-3.21M	3.00M	-1.54M	-898.00K	-1.13M	8.39M	12.88M	28.85M	17.96M
Shares Outstanding (Basic)	84.60M	72.71M	67.51M	58.01M	43.46M	36.17M	30.10M	28.11M	24.33M	19.39M	17.74M	7.18M	7.18M
Shares Outstanding (Diluted)	84.60M	72.71M	67.51M	58.01M	43.46M	36.17M	30.10M	28.11M	24.34M	19.39M	17.74M	7.18M	7.18M
EPS (Basic)	-3.83	-4.9	-4.25	-4.86	-3.59	-3.94	-4.01	-3.18	-3.02	-3.24	-2.96	-8.12	-6.25
EPS (Diluted)	-3.83	-4.9	-4.25	-4.86	-3.59	-3.94	-4.01	-3.18	-3.02	-3.24	-2.96	-8.12	-6.25
EBITDA	-290.64M	-305.52M	-255.18M	-259.31M	-156.52M	-137.80M	-118.66M	-86.74M	-70.29M	-50.00M	-35.40M	-27.52M	-25.09M
Depreciation & Amortization	13.69M	33.73M	19.85M	10.25M	2.91M	1.73M	1.47M	1.45M	2.00M	2.05M	1.88M	1.78M	1.98M